$273 Million is the total value of Iguana Healthcare Management, LLC's 75 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 104.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORP | $17,516,000 | -26.9% | 175,000 | -12.5% | 6.42% | -18.6% |
| CI | Sell | CIGNA CORPORATION | $13,724,000 | -30.5% | 100,000 | -25.9% | 5.03% | -22.6% |
| New | SPDR SERIES TRUSTput | $12,916,000 | – | 250,000 | +100.0% | 4.73% | – | |
| MDVN | Buy | MEDIVATION INC | $12,185,000 | +404.1% | 265,000 | +430.0% | 4.46% | +461.6% |
| BAX | Sell | BAXTER INTL INC | $11,913,000 | -3.9% | 290,000 | -10.8% | 4.36% | +7.0% |
| New | ISHARES TRput | $11,063,000 | – | 100,000 | +100.0% | 4.05% | – | |
| New | SPDR S&P 500 ETF TRput | $10,276,000 | – | 50,000 | +100.0% | 3.76% | – | |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $9,064,000 | – | 85,000 | +100.0% | 3.32% | – |
| MRK | Buy | MERCK & CO INC NEW | $7,937,000 | +50.3% | 150,000 | +50.0% | 2.91% | +67.3% |
| BIIB | Buy | BIOGEN INC | $7,810,000 | +27.5% | 30,000 | +50.0% | 2.86% | +42.0% |
| GILD | Sell | GILEAD SCIENCES INC | $7,808,000 | -14.3% | 85,000 | -5.6% | 2.86% | -4.5% |
| HCA | New | HCA HOLDINGS INC | $7,805,000 | – | 100,000 | +100.0% | 2.86% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $7,597,000 | -41.1% | 120,000 | +4.3% | 2.78% | -34.4% |
| MDT | New | MEDTRONIC PLC | $7,500,000 | – | 100,000 | +100.0% | 2.75% | – |
| PFE | New | PFIZER INC | $5,928,000 | – | 200,000 | +100.0% | 2.17% | – |
| LLY | New | LILLY ELI & CO | $5,401,000 | – | 75,000 | +100.0% | 1.98% | – |
| AMGN | Sell | AMGEN INC | $5,248,000 | -67.7% | 35,000 | -65.0% | 1.92% | -64.0% |
| New | BIOGEN INCcall | $5,206,000 | – | 20,000 | +100.0% | 1.91% | – | |
| THC | Buy | TENET HEALTHCARE CORP | $5,063,000 | +122.7% | 175,000 | +133.3% | 1.86% | +148.0% |
| NUVA | Buy | NUVASIVE INC | $4,865,000 | +79.8% | 100,000 | +100.0% | 1.78% | +100.3% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $4,722,000 | -47.6% | 467,025 | +16.8% | 1.73% | -41.7% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $4,194,000 | +108.0% | 275,000 | +83.3% | 1.54% | +131.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $3,965,000 | +11.5% | 250,000 | +127.3% | 1.45% | +24.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $3,766,000 | +60.0% | 60,000 | +140.0% | 1.38% | +78.1% |
| BSX | New | BOSTON SCIENTIFIC CORP | $3,762,000 | – | 200,000 | +100.0% | 1.38% | – |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTN | $3,303,000 | -21.9% | 250,000 | -9.1% | 1.21% | -13.1% |
| New | BRISTOL MYERS SQUIBB COcall | $3,194,000 | – | 50,000 | +100.0% | 1.17% | – | |
| New | INCYTE CORPcall | $2,899,000 | – | 40,000 | +100.0% | 1.06% | – | |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $2,892,000 | +70.2% | 200,000 | +233.3% | 1.06% | +89.6% |
| New | REGENERON PHARMACEUTICALSput | $2,703,000 | – | 7,500 | +100.0% | 0.99% | – | |
| REGN | New | REGENERON PHARMACEUTICALS | $2,703,000 | – | 7,500 | +100.0% | 0.99% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $2,694,000 | – | 140,000 | +100.0% | 0.99% | – |
| New | MERCK & CO INC NEWput | $2,646,000 | – | 50,000 | +100.0% | 0.97% | – | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,474,000 | – | 30,000 | +100.0% | 0.91% | – |
| KITE | New | KITE PHARMA INC | $2,296,000 | – | 50,000 | +100.0% | 0.84% | – |
| HWAY | HEALTHWAYS INC | $2,270,000 | -21.6% | 225,000 | 0.0% | 0.83% | -12.7% | |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $2,123,000 | +23.3% | 100,000 | +33.3% | 0.78% | +37.2% |
| GKOS | New | GLAUKOS CORP | $2,108,000 | – | 125,000 | +100.0% | 0.77% | – |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,033,000 | -52.3% | 250,000 | -29.2% | 0.74% | -46.8% |
| BKD | Sell | BROOKDALE SR LIVING INC | $1,985,000 | -28.3% | 125,000 | -16.7% | 0.73% | -20.2% |
| XLRN | Sell | ACCELERON PHARMA INC | $1,979,000 | -72.9% | 75,000 | -50.0% | 0.72% | -69.9% |
| New | GW PHARMACEUTICALS PLCcall | $1,804,000 | – | 25,000 | +100.0% | 0.66% | – | |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $1,796,000 | -52.2% | 125,000 | -28.6% | 0.66% | -46.8% |
| New | MEDIVATION INCcall | $1,609,000 | – | 35,000 | +100.0% | 0.59% | – | |
| IPXL | IMPAX LABORATORIES INC | $1,601,000 | -25.1% | 50,000 | 0.0% | 0.59% | -16.5% | |
| SPNC | Buy | SPECTRANETICS CORP | $1,597,000 | +112.1% | 110,000 | +120.0% | 0.58% | +135.9% |
| New | ALNYLAM PHARMACEUTICALS INCput | $1,569,000 | – | 25,000 | +100.0% | 0.58% | – | |
| MZOR | Buy | MAZOR ROBOTICS LTDsponsored ads | $1,555,000 | +512.2% | 125,000 | +400.0% | 0.57% | +578.6% |
| DERM | DERMIRA INC | $1,551,000 | -40.3% | 75,000 | 0.0% | 0.57% | -33.5% | |
| LDRH | New | LDR HLDG CORP | $1,529,000 | – | 60,000 | +100.0% | 0.56% | – |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $1,398,000 | -54.3% | 100,000 | -33.3% | 0.51% | -49.2% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $1,390,000 | – | 50,000 | +100.0% | 0.51% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $1,307,000 | – | 150,000 | +100.0% | 0.48% | – |
| CYTK | Sell | CYTOKINETICS INC | $1,234,000 | -66.3% | 175,000 | -50.0% | 0.45% | -62.5% |
| PETX | New | ARATANA THERAPEUTICS INC | $1,104,000 | – | 200,000 | +100.0% | 0.40% | – |
| TNET | New | TRINET GROUP INC | $1,076,000 | – | 75,000 | +100.0% | 0.39% | – |
| BLUE | New | BLUEBIRD BIO INC | $1,063,000 | – | 25,000 | +100.0% | 0.39% | – |
| Buy | ONCOMED PHARMACEUTICALS INCcall | $1,011,000 | -10.3% | 100,000 | +100.0% | 0.37% | -0.3% | |
| New | SAREPTA THERAPEUTICS INCcall | $976,000 | – | 50,000 | +100.0% | 0.36% | – | |
| HTWR | Sell | HEARTWARE INTL INC | $943,000 | -73.3% | 30,000 | -57.1% | 0.35% | -70.2% |
| AERI | New | AERIE PHARMACEUTICALS INC | $912,000 | – | 75,000 | +100.0% | 0.33% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $881,000 | -55.1% | 30,000 | +20.0% | 0.32% | -49.9% |
| RXDX | Sell | IGNYTA INC | $846,000 | -60.5% | 125,000 | -21.9% | 0.31% | -56.0% |
| FLDM | New | FLUIDIGM CORP DEL | $807,000 | – | 100,000 | +100.0% | 0.30% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $778,000 | – | 75,000 | +100.0% | 0.28% | – |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $639,000 | -48.9% | 100,000 | -50.0% | 0.23% | -43.1% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $638,000 | – | 75,000 | +100.0% | 0.23% | – |
| EXEL | New | EXELIXIS INC | $600,000 | – | 150,000 | +100.0% | 0.22% | – |
| GI | New | ENDOCHOICE HLDGS INC | $599,000 | – | 115,000 | +100.0% | 0.22% | – |
| FWP | New | FORWARD PHARMA A/Ssponsored adr | $510,000 | – | 30,000 | +100.0% | 0.19% | – |
| SCYX | SCYNEXIS INC | $504,000 | -35.1% | 125,000 | 0.0% | 0.18% | -27.5% | |
| SGMO | Sell | SANGAMO BIOSCIENCES INC | $454,000 | -75.1% | 75,000 | -62.5% | 0.17% | -72.4% |
| New | DERMIRA INCput | $414,000 | – | 20,000 | +100.0% | 0.15% | – | |
| New | ACCELERATE DIAGNOSTICS INCcall | $359,000 | – | 25,000 | +100.0% | 0.13% | – | |
| New | ARIAD PHARMACEUTICALS INCcall | $320,000 | – | 50,000 | +100.0% | 0.12% | – | |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.10% | – |
| GENN | Exit | GENESIS HEALTHCARE INC | $0 | – | -100,000 | -100.0% | -0.11% | – |
| PPHM | Exit | PEREGRINE PHARMACEUTICALS IN | $0 | – | -500,000 | -100.0% | -0.19% | – |
| WOOF | Exit | VCA INC | $0 | – | -15,000 | -100.0% | -0.27% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -0.37% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -400,000 | -100.0% | -0.40% | – |
| Exit | ILLUMINA INCput | $0 | – | -7,500 | -100.0% | -0.47% | – | |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -75,000 | -100.0% | -0.54% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -100,000 | -100.0% | -0.60% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -75,000 | -100.0% | -0.70% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -35,000 | -100.0% | -0.71% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -150,000 | -100.0% | -0.73% | – |
| Exit | STRYKER CORPcall | $0 | – | -25,000 | -100.0% | -0.76% | – | |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -25,000 | -100.0% | -0.84% | – |
| NVDQ | Exit | NOVADAQ TECHNOLOGIES INC | $0 | – | -200,000 | -100.0% | -0.84% | – |
| Exit | ZIMMER BIOMET HLDGS INCcall | $0 | – | -25,000 | -100.0% | -0.84% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.96% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -110,000 | -100.0% | -0.98% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -125,000 | -100.0% | -1.07% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.26% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.27% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -60,687 | -100.0% | -1.39% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -75,000 | -100.0% | -1.51% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -60,000 | -100.0% | -1.73% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -50,000 | -100.0% | -1.78% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -150,000 | -100.0% | -3.24% | – |
| MYL | Exit | MYLAN N V | $0 | – | -225,000 | -100.0% | -4.00% | – |
| Exit | SELECT SECTOR SPDR TRput | $0 | – | -500,000 | -100.0% | -11.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.